The secondary outcomes included (1) the correlation between IFITM1/2/3 levels and coronary stenosis severity quantified by Gensini score, and (2) the differential expression of IFITM1/2/3 in AMI patients with and without heart failure. Here, IFITM1 is linked to heart failure.